Patients with D2T RA experience more noninflammatory pain vs those without D2T disease who were responsive to treatment with b/tsDMARDs.

A federal judge said Amgen must face a proposed class action accusing the drugmaker of waiting too long to tell shareholders ...

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial. Neurotrophin-3 (NT-3 ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Fortunately, there are several pain relief medications made specifically for dogs, as well as holistic treatment options. Your veterinarian is your best resource to speak to if you worry that your dog ...

Biosimilars have emerged as a significant advancement in the field of rheumatology, offering a new paradigm in the treatment ...

UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

A summary of research written by Vibeke Strand, MD, clinical professor in division of immunology/rheumatology at Stanford ...

In Czechia, over 160,000 people and approximately 4,000 children are living with rheumatoid arthritis. While modern medicine ...

Ibuprofen for headaches, aspirin for heart health, antibiotics for infections, multivitamins you may not necessarily need — ...

Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic conditions, and ...